(Q35588886)

English

Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation

scientific article published on December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation (English)

1 reference

Europe PubMed Central

9 August 2017

1 reference

based on heuristic

inferred from title

author name string

Shien T

1

1 reference

Europe PubMed Central

9 August 2017

Tashiro T

2

1 reference

Europe PubMed Central

9 August 2017

Omatsu M

3

1 reference

Europe PubMed Central

9 August 2017

Masuda T

4

1 reference

Europe PubMed Central

9 August 2017

Furuta K

5

1 reference

Europe PubMed Central

9 August 2017

Sato N

6

1 reference

Europe PubMed Central

9 August 2017

Akashi-Tanaka S

7

1 reference

Europe PubMed Central

9 August 2017

Uehara M

8

1 reference

Europe PubMed Central

9 August 2017

Iwamoto E

9

1 reference

Europe PubMed Central

9 August 2017

Kinoshita T

10

1 reference

Europe PubMed Central

9 August 2017

Fukutomi T

11

1 reference

Europe PubMed Central

9 August 2017

Tsuda H

12

1 reference

Europe PubMed Central

9 August 2017

Hasegawa T

13

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

9 August 2017

Journal of Clinical Pathology

1 reference

Europe PubMed Central

9 August 2017

58

1 reference

Europe PubMed Central

9 August 2017

12

1 reference

Europe PubMed Central

9 August 2017

1299-1304

1 reference

Europe PubMed Central

9 August 2017

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

12 July 2018

Therapeutic potential of tyrosine kinase inhibitors in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

12 July 2018

Differential Amplification and Overexpression of HER-2/neu, p53, MIB1, and Estrogen Receptor/Progesterone Receptor Among Medullary Carcinoma, Atypical Medullary Carcinoma, and High-Grade Invasive Ductal Carcinoma of Breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

12 July 2018

CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

12 July 2018

Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

12 July 2018

p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

12 July 2018

Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

12 July 2018

Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

12 July 2018

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

12 July 2018

beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

26 September 2018

Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

26 September 2018

Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

26 September 2018

Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

26 September 2018

Assessment of HER‐2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

26 September 2018

A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

26 September 2018

Metaplastic breast carcinoma: pathology and clinical outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

26 September 2018

Metaplastic carcinomas of the breast. II. Spindle cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770787

26 September 2018

Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metaplastic carcinomas of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metaplastic carcinomas of the breast. III. Carcinosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of p53 protein in infiltrating and in-situ breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16311351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JCP.2005.026096

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35588886&oldid=1580709010"